Clinical Trial Update: Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update reports on the efficacy and tolerability of adding pegylated interferon alfa-2a to the standard HIV/HBV regimen (tenofovir and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Emtricitabine (Emtricitabine)
• Pegasys (pegylated interferon alfa-2a)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Hepatitis B, HIV Infections | Phase 2, Phase 3 | Status: COMPLETED